Harel Insurance Investments & Financial Services Ltd. Medi Wound Ltd. Transaction History

Harel Insurance Investments & Financial Services Ltd.

  • $6.11 Billion
  • Q4 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 27, 2021
SELL
$3.77 - $6.05 $54,861 - $88,039
-14,552 Closed
0 $0
Q2 2020

Jul 14, 2020
SELL
$1.47 - $2.97 $127,638 - $257,882
-86,829 Reduced 85.65%
14,552 $43,000
Q1 2020

Apr 28, 2020
SELL
$1.57 - $3.1 $637,754 - $1.26 Million
-406,213 Reduced 80.03%
101,381 $159,000
Q4 2019

Jan 23, 2020
SELL
$2.72 - $3.15 $671,404 - $777,546
-246,840 Reduced 32.72%
507,594 $1.57 Million
Q4 2017

Feb 01, 2018
BUY
$4.25 - $5.2 $3.14 Million - $3.85 Million
739,882 Added 5084.4%
754,434 $3.36 Million
Q3 2017

Nov 02, 2017
BUY
$4.8 - $6.95 $69,849 - $101,136
14,552
14,552 $73,000

About MediWound Ltd.

MDWD Quotes by TradingView
  • Ticker MDWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,735,200
  • Market Cap $739M
  • Description
  • MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...
More about MDWD
Track This Portfolio

Track Harel Insurance Investments & Financial Services Ltd. Portfolio

Follow Harel Insurance Investments & Financial Services Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email